Our flagship instruments for DNA electrophoresis native gel runs — engineered for accuracy, durability and seamless lab integration.
DNA electrophoresis for native gel runs is a fundamental analytical technique used to separate, identify, and characterize DNA molecules based on their size, shape, and charge — without the use of denaturing agents such as SDS. Unlike denaturing gel electrophoresis, native gel electrophoresis preserves the three-dimensional conformation of DNA molecules, making it invaluable for studying DNA–protein interactions, supercoiled plasmid topology, and higher-order DNA structures.
In a native gel system, DNA migrates through a polyacrylamide or agarose matrix under the influence of an electric field. Since all DNA molecules carry a net negative charge due to their phosphate backbone, they migrate toward the positive electrode. However, the rate of migration is influenced not only by molecular weight but also by the native conformation — circular, linear, or supercoiled — making native gels particularly sensitive to structural differences that denaturing systems cannot distinguish.
The technique is widely used across molecular biology, biochemistry, clinical diagnostics, pharmaceutical development, and industrial biotechnology. From verifying plasmid integrity to characterizing nucleic acid–ligand interactions, native gel electrophoresis remains a cornerstone analytical method in the modern life science laboratory.
Modern native gel electrophoresis systems combine high-resolution separation with quantitative imaging, enabling researchers to not only visualize bands but also quantify DNA concentrations, analyze fragment distributions, and assess molecular integrity with unprecedented precision.
From fundamental genomics research to cutting-edge industrial biomanufacturing, native gel DNA electrophoresis powers critical workflows across multiple sectors.
Native gels enable electrophoretic mobility shift assays (EMSA), revealing how transcription factors, polymerases, and other proteins bind to specific DNA sequences — critical for drug target identification.
Biopharmaceutical companies use native gel runs to verify plasmid topology, assess vector integrity, and ensure quality of viral vectors for gene therapy products prior to clinical release.
Native gel electrophoresis is deployed in food safety laboratories and agricultural R&D to detect genetic modifications in crops, verify hybrid integrity, and support precision breeding programs.
In clinical laboratories and forensic investigation, native gel electrophoresis assists in pathogen detection, cancer biomarker profiling, and identity verification through DNA fingerprinting techniques.
Researchers studying G-quadruplexes, cruciform structures, and DNA origami rely on native gels to resolve complex conformational landscapes that cannot be captured by any other rapid analytical tool.
In large-scale bioprocessing facilities, native gel runs serve as critical inline quality checkpoints to validate DNA templates for enzyme production, fermentation optimization, and biosecurity compliance.
The global electrophoresis market is evolving rapidly, driven by the convergence of genomics, AI-driven diagnostics, and industrial bioproduction demands.
The global electrophoresis market was valued at over USD 3.5 billion in 2023 and is projected to grow at a CAGR of 6.8% through 2030, driven by surging investment in genomics, proteomics, and personalized medicine research globally.
Next-generation native gel systems now incorporate AI-powered image analysis software that automatically detects bands, calculates fragment sizes, and generates quantitative reports — reducing human error and dramatically increasing throughput.
Lab-on-chip native gel electrophoresis platforms are gaining traction, enabling high-throughput DNA analysis with microgram-scale samples. These systems are ideal for point-of-care diagnostics and field-deployable genomics applications.
The explosive growth of mRNA vaccines and CRISPR-based gene therapies has created a surge in demand for high-precision native gel analysis to verify RNA/DNA structural integrity throughout the manufacturing pipeline.
The industry is moving toward eco-friendly gel staining reagents, reduced-power electrophoresis systems, and recyclable buffer systems — aligning with global sustainability goals and regulatory requirements in the EU and beyond.
Modern native gel systems are increasingly integrated with LIMS (Laboratory Information Management Systems), allowing real-time data capture, traceability, and cloud-based result sharing for collaborative global research workflows.
Beijing Liuyi Biotechnology Co., Ltd., formerly known as Beijing Liuyi Instrument Factory, established in 1970, is a national high technology enterprise with a long history. It is a leading and the biggest manufacturer in electrophoresis instrument for life science laboratories in China.
Based on the life science and biotechnology industries, our mainly products always in the domestic industry leading firm and well-known in the industry, exported to other countries and areas. We have our own R&D team, open to scientific research innovation, market development first, industry and combined with the development, the economic scale of our company have rapid growth for several years.
Liuyi has specialized in manufacturing electrophoresis instruments for more than 50 years with our own professional technical team and R&D center. We have reliable and complete production line from design to inspection, and warehouse, as well as marketing support. Our main products are Electrophoresis Cell (tank/chamber), Electrophoresis Power Supply, Blu LED Transilluminator, UV Transilluminator, Gel Image & Analysis System etc. According to your requirements, we can provide customized service for you.
Liuyi has been awarded variety certificates and enterprise qualifications along with its high reputation in industry. We are ISO 9001 & ISO 13485 certified company and some of our products have CE certificates. Since 2003, Liuyi as the only medical device manufacturer in Beijing medical industry has been awarded as "PROMISE-KEEPING ENTERPRISE" by Beijing Administration for Industry and Commerce.
In 2008, Liuyi is honored as the famous trademark of Beijing. Our trademark is under the protection of Madrid Protocol in 7 countries including the United States, the United Kingdom, Japan, South Korea, Singapore, Greece, and Zambia in 2005, as well we have registered our trademark in India and Vietnam.
Based on life science and biotechnology industry, with excellent reputation, we offer reliable quality products and good service to our customers in China and overseas. We are the key supplier for the government purchase projects, and we have nearly 2000 dealers in China. Our products have been exported to more than ten countries including America, Brazil, Mexico, India, Africa, Chile, Singapore etc. We are dedicated to offering our products throughout the world.
Beijing Liuyi Biotechnology Co., Ltd has launched new products for protein analysis, western blotting and gel observation. DYCZ-MINI series are fully compatible with the main international brands, and can run up to four precast or handcast polyacrylamide gels. The trans-blot module of DYCZ-TRANS2 is compatible with the chamber of DYCZ-MINI series. The WD-9403B can observe gel for nucleic acid electrophoresis. These new products are all durable, versatile, and easy to assemble. Welcome to contact us for more details!
Explore our full lineup of electrophoresis instruments, power supplies and imaging systems — all designed for native gel DNA analysis workflows.